Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$469,056
+$215,898 QoQ
Shares Held
1,864
+60.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#3,230
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Fiduciary Investment Counsel, Inc. holds $51,339,791 across 7 Drug Manufacturers - General names. ABBV ranks #7 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
73,221 | $18,595,937 | |
| 2 | NVS |
Novartis AG
|
99,224 | $15,550,385 | |
| 3 | AMGN |
Amgen Inc
|
25,171 | $9,114,922 | |
| 4 | PFE |
Pfizer Inc
|
256,357 | $6,173,076 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,118 | $914,663 | |
| 6 | LLY |
ELI LILLY & Co
|
435 | $521,752 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
1,864 | $469,056 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $469,056 | 1,864 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $253,158 | 1,164 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $951,432 | 4,164 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,010,440 | 4,364 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $810,045 | 4,364 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $882,917 | 4,214 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $748,827 | 4,214 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $832,180 | 4,214 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $722,785 | 4,214 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $767,369 | 4,214 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $668,540 | 4,314 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $623,517 | 4,183 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $513,051 | 3,808 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $606,880 | 3,808 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $615,410 | 3,808 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $469,735 | 3,500 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $536,060 | 3,500 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $567,385 | 3,500 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $473,900 | 3,500 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $377,545 | 3,500 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $394,240 | 3,500 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $378,770 | 3,500 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $375,025 | 3,500 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $306,565 | 3,500 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $343,630 | 3,500 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $266,665 | 3,500 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||